MK021
A 24-Week, Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Assess Anacetrapib When Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low HDL-C
- Stage
- klaar
- Medicine
- Anacetrapib
- Population
- Diabetes Mellitus
- Phase
- III
- First Patient In
- 1 January 2012
- Last Patient In
- -
- Last Patient Last Visit
- -
Board Contact
